{"title":"Spanning 17 Years: Diagnostic Evolution from Lichen Planus Pigmentosus to Hyperpigmented Mycosis Fungoides.","authors":"WeiFeng Zha, JunWei Lu","doi":"10.2147/CCID.S541051","DOIUrl":null,"url":null,"abstract":"<p><p>Lichen planus pigmentosus (LPP) and hyperpigmented mycosis fungoides (MF) represent two distinct rare cutaneous disorders. This case explores the potential association between LPP and hyperpigmented MF, a previously unreported progression. The authors report a 52-year-old male presenting with purplish-red macules on the abdomen and upper extremities subsequent to exposure to petrochemicals, initially diagnosed in 2007 with lichen planus (LP). In 2019, LPP was confirmed by histopathological evaluation of a skin biopsy obtained from an outside institution. Despite treatment with hydroxychloroquine sulfate tablets, the lesions exhibited disease progression. After 17 years, generalized hyperpigmentation gradually developed. Repeat biopsies and immunohistochemistry were performed in 2024, leading to the definitive diagnosis of hyperpigmented MF. The patient is currently managed with subcutaneous interferon alpha-2b (IFNα-2b) injections, with the rash color showing slight lightening. In conclusion, the cutaneous manifestations of MF demonstrate marked heterogeneity, requiring systematic clinical evaluation and histopathological assessment to facilitate accurate diagnosis and guide the development of stage-appropriate treatment protocols. Whether the transformation from LPP to hyperpigmented MF is rare, impossible, or a missed diagnosis remains to be further clarified with more reported cases.</p>","PeriodicalId":10447,"journal":{"name":"Clinical, Cosmetic and Investigational Dermatology","volume":"18 ","pages":"2297-2302"},"PeriodicalIF":2.2000,"publicationDate":"2025-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12435356/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical, Cosmetic and Investigational Dermatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/CCID.S541051","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Lichen planus pigmentosus (LPP) and hyperpigmented mycosis fungoides (MF) represent two distinct rare cutaneous disorders. This case explores the potential association between LPP and hyperpigmented MF, a previously unreported progression. The authors report a 52-year-old male presenting with purplish-red macules on the abdomen and upper extremities subsequent to exposure to petrochemicals, initially diagnosed in 2007 with lichen planus (LP). In 2019, LPP was confirmed by histopathological evaluation of a skin biopsy obtained from an outside institution. Despite treatment with hydroxychloroquine sulfate tablets, the lesions exhibited disease progression. After 17 years, generalized hyperpigmentation gradually developed. Repeat biopsies and immunohistochemistry were performed in 2024, leading to the definitive diagnosis of hyperpigmented MF. The patient is currently managed with subcutaneous interferon alpha-2b (IFNα-2b) injections, with the rash color showing slight lightening. In conclusion, the cutaneous manifestations of MF demonstrate marked heterogeneity, requiring systematic clinical evaluation and histopathological assessment to facilitate accurate diagnosis and guide the development of stage-appropriate treatment protocols. Whether the transformation from LPP to hyperpigmented MF is rare, impossible, or a missed diagnosis remains to be further clarified with more reported cases.
期刊介绍:
Clinical, Cosmetic and Investigational Dermatology is an international, peer-reviewed, open access journal that focuses on the latest clinical and experimental research in all aspects of skin disease and cosmetic interventions. Normal and pathological processes in skin development and aging, their modification and treatment, as well as basic research into histology of dermal and dermal structures that provide clinical insights and potential treatment options are key topics for the journal.
Patient satisfaction, preference, quality of life, compliance, persistence and their role in developing new management options to optimize outcomes for target conditions constitute major areas of interest.
The journal is characterized by the rapid reporting of clinical studies, reviews and original research in skin research and skin care.
All areas of dermatology will be covered; contributions will be welcomed from all clinicians and basic science researchers globally.